Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives
Srimanta Patra, Soumya Ranjan Mishra, Bishnu Prasad Behera, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 205-217
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 364
The interplay of ROS and the PI3K/Akt pathway in autophagy regulation
Lakhan Kma, Taranga Jyoti Baruah
Biotechnology and Applied Biochemistry (2021) Vol. 69, Iss. 1, pp. 248-264
Closed Access | Times Cited: 245
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Cancer Letters (2021) Vol. 509, pp. 63-80
Closed Access | Times Cited: 196
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 153
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 151
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 138
Dietary polyphenols in chemoprevention and synergistic effect in cancer: Clinical evidences and molecular mechanisms of action
Srimanta Patra, Biswajita Pradhan, Rabindra Nayak, et al.
Phytomedicine (2021) Vol. 90, pp. 153554-153554
Closed Access | Times Cited: 121
Phytochemicals as a Complement to Cancer Chemotherapy: Pharmacological Modulation of the Autophagy-Apoptosis Pathway
Md. Ataur Rahman, Md. Abdul Hannan, Raju Dash, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis
Afshin Taheriazam, Ghazaleh Gholamiyan Yousef Abad, Shima Hajimazdarany, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 503-522
Open Access | Times Cited: 55
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, et al.
Life Sciences (2020) Vol. 256, pp. 117984-117984
Closed Access | Times Cited: 136
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 102
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 97
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 349-349
Open Access | Times Cited: 95
Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
Milad Ashrafizadeh, Mohammad Reza Bakhoda, Zahra Bahmanpour, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 91
Rationalizing the therapeutic potential of apigenin against cancer
Semim Akhtar Ahmed, Parama Dey, Enush Daimari, et al.
Life Sciences (2020) Vol. 267, pp. 118814-118814
Closed Access | Times Cited: 90
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.
Bioengineering (2020) Vol. 7, Iss. 3, pp. 91-91
Open Access | Times Cited: 85
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Milad Ashrafizadeh, Ali Zarrabi, Maryam Hashemipour, et al.
Pharmacological Research (2020) Vol. 160, pp. 105199-105199
Closed Access | Times Cited: 76
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
Sepideh Mirzaei, Ali Zarrabi, Sholeh Etehad Asnaf, et al.
Life Sciences (2021) Vol. 268, pp. 119005-119005
Closed Access | Times Cited: 72
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
Milad Ashrafizadeh, Mohammad Gholami, Sepideh Mirzaei, et al.
Life Sciences (2021) Vol. 270, pp. 119006-119006
Closed Access | Times Cited: 67
Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives
Srimanta Patra, Biswajita Pradhan, Rabindra Nayak, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4194-4214
Closed Access | Times Cited: 63
Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis
Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 103-120
Closed Access | Times Cited: 57
Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends
Jamileh Kadkhoda, Ali Tarighatnia, Mohammad Reza Tohidkia, et al.
Life Sciences (2022) Vol. 298, pp. 120499-120499
Closed Access | Times Cited: 54
Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
Wenfeng Zhang, Cun Liu, Jie Li, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 01, pp. 209-239
Closed Access | Times Cited: 53
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top